Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Bioceres Crop Solutions (BIOX) EBIAT (2016 - 2026)

Bioceres Crop Solutions' EBIAT history spans 5 years, with the latest figure at -$10.0 million for Q1 2026.

  • On a quarterly basis, EBIAT fell 534.78% to -$10.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$19.3 million, a 49.82% decrease, with the full-year FY2025 number at -$58.8 million, down 907.32% from a year prior.
  • EBIAT hit -$10.0 million in Q1 2026 for Bioceres Crop Solutions, down from $2.3 million in the prior quarter.
  • Over the last five years, EBIAT for BIOX hit a ceiling of $2.3 million in Q1 2025 and a floor of -$10.0 million in Q1 2026.
  • Historically, EBIAT has averaged -$5.4 million across 3 years, with a median of -$8.6 million in 2022.
  • Biggest five-year swings in EBIAT: tumbled 182.11% in 2022 and later crashed 534.78% in 2026.
  • Tracing BIOX's EBIAT over 3 years: stood at -$8.6 million in 2022, then soared by 126.86% to $2.3 million in 2025, then crashed by 534.78% to -$10.0 million in 2026.
  • Business Quant data shows EBIAT for BIOX at -$10.0 million in Q1 2026, $2.3 million in Q1 2025, and -$8.6 million in Q2 2022.